Anti-Therapeutic Action: itraconazole resistance

Insights into Persian Gulf Beach Sand Mycobiomes: Promises and Challenges in Fungal Diversity

mycolabadmin

Researchers studied fungi living in sand and water along Persian Gulf beaches to understand potential health risks for swimmers. They found that fungal species, particularly Aspergillus terreus, were abundant in beach sand, with some fungi showing resistance to common antifungal medicines. The study suggests beaches need better monitoring and sanitation practices to protect public health, especially during busy bathing seasons when many visitors enjoy the coast.

Read More »

The association of Yarrowia lipolytica with onychomycosis

mycolabadmin

A 20-year-old woman suffered from a persistent toenail infection that didn’t respond to several standard antifungal treatments over five years. Researchers identified the culprit as Yarrowia lipolytica, a rare yeast not previously known to cause nail infections. Testing showed this yeast was resistant to common antifungal medications the patient had received, explaining why previous treatments failed. This unusual case highlights the importance of properly identifying fungal pathogens and testing them for drug resistance before starting treatment.

Read More »

Overexpression of efflux pump and biofilm associated genes in itraconazole resistant Candida albicans isolates causing onychomycosis

mycolabadmin

This study examined why some fungal nail infections caused by Candida albicans don’t respond to itraconazole treatment. Researchers found that resistant fungi have higher levels of genes that pump the antifungal drug out of their cells and genes that help them form protective biofilm layers. These findings suggest that combining itraconazole with drugs that block these pumps or disrupt biofilms could be more effective for treating stubborn fungal nail infections.

Read More »
Scroll to Top